Discover undervalued stocks with Eulerpool.

Subscribe for $2

DocGo Stock DCGO

Price

0
Today +/-
-0
Today %
-0 %

DocGo stock price

Loading chart...
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the DocGo stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the DocGo stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the DocGo stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze DocGo's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

DocGo Stock Price History

DateDocGo Price
9/26/20250 undefined
9/25/20251.37 undefined
9/24/20251.39 undefined
9/24/20251.46 undefined
9/23/20251.47 undefined
9/22/20251.49 undefined
9/19/20251.46 undefined
9/19/20251.44 undefined
9/18/20251.55 undefined
9/17/20251.53 undefined
9/16/20251.55 undefined
9/15/20251.57 undefined
9/12/20251.54 undefined
9/11/20251.55 undefined
9/10/20251.57 undefined
9/9/20251.59 undefined
9/8/20251.58 undefined
9/5/20251.58 undefined
9/4/20251.52 undefined
9/3/20251.57 undefined
9/2/20251.51 undefined
8/29/20251.56 undefined

DocGo Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into DocGo, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by DocGo from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects DocGo’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of DocGo. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into DocGo’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing DocGo’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on DocGo’s growth potential.

DocGo Revenue, EBIT and net profit per share

DateDocGo RevenueDocGo EBITDocGo Net Income
2027e355.1 M undefined-25.73 M undefined-20.65 M undefined
2026e322.9 M undefined-44.34 M undefined-19.61 M undefined
2025e324.34 M undefined-64.02 M undefined-49.56 M undefined
2024616.56 M undefined28.69 M undefined19.99 M undefined
2023624.29 M undefined15.32 M undefined6.86 M undefined
2022440.5 M undefined32.1 M undefined34.6 M undefined
2021318.7 M undefined19.3 M undefined23.7 M undefined
202094.1 M undefined-11.1 M undefined-14.4 M undefined

DocGo Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
202020212022202320242025e2026e2027e
94318440624616324322355
-238.3038.3641.82-1.28-47.40-0.6210.25
32.9834.2835.0031.2534.5865.7466.1560.00
31109154195213000
-142334619-49-19-20
--264.2947.83-82.35216.67-357.89-61.225.26
58.494.9103105.62109.42000
- - - - - - - -
Details

Keystats

ⓘ

Revenue and Growth

The DocGo Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the DocGo is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (M)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (M)
TOTAL ASSETS (M)
LIABILITIES
COMMON STOCK (k)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (M)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (M)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (M)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (M)
DEBT (M)
TOTAL CAPITAL (M)
20202021202220232024
         
32.4175.5157.359.2989.24
24.978.4103262.08210.9
00000
00000
1.22.110.817.54.34
58.5256271.1338.87304.49
21.126.239.438.4242.18
00.60.60.555.55
00000
10.710.72337.6825.73
6.68.738.947.5447.43
3.47.420.427.3930.25
41.853.6122.3151.58151.13
100.3309.6393.4490.45455.62
         
00010.410.2
142.3283.2301.5320.69321.09
-87.3-63.6-29-21.39-1.4
000.71.481.22
00000
55219.6273.2300.79320.92
415.821.619.8328.36
14.135.833.291.7651.14
2.92.34229.977.61
0002530
2.53.93.43.564.71
23.557.8100.2170.12121.81
6.18.27.27.9410.04
00000
3.616.577.228.6
9.724.714.215.1618.64
33.282.5114.4185.28140.44
88.2302.1387.6486.08461.36
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of DocGo provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand DocGo's financial health and stability.

Assets

DocGo's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that DocGo must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of DocGo after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into DocGo's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (k)
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
2020202120222023
-14193010
571016
00-9-1
-3-28-13-113
211845
0000
0014
-10-128-64
-6-6-5-10
-6-8-38-29
0-1-32-19
0000
-2-2-320
0178-11
0155-61
1,000-20,0000-21,000
0000
-17144-15-91
-16.97-8.6623.37-74.35
0000

DocGo stock margins

The DocGo margin analysis displays the gross margin, EBIT margin, as well as the profit margin of DocGo. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for DocGo.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the DocGo's sales revenue. A higher gross margin percentage indicates that the DocGo retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the DocGo's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the DocGo's total revenue generated. When comparing the revenue margin year over year, investors can gauge the DocGo's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the DocGo. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the DocGo's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

DocGo Margin History

DocGo Gross marginDocGo Profit marginDocGo EBIT marginDocGo Profit margin
2027e34.64 %-7.24 %-5.81 %
2026e34.64 %-13.73 %-6.07 %
2025e34.64 %-19.74 %-15.28 %
202434.64 %4.65 %3.24 %
202331.3 %2.45 %1.1 %
202235.12 %7.29 %7.85 %
202134.42 %6.06 %7.44 %
202033.26 %-11.8 %-15.3 %

DocGo Stock Sales Revenue, EBIT, Earnings per Share

The DocGo earnings per share therefore indicates how much revenue DocGo has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue DocGo earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates DocGo's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of DocGo’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating DocGo's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

DocGo Revenue, EBIT and net profit per share

DateDocGo Sales per ShareDocGo EBIT per shareDocGo Earnings per Share
2027e3.25 undefined0 undefined-0.19 undefined
2026e2.95 undefined0 undefined-0.18 undefined
2025e2.96 undefined0 undefined-0.45 undefined
20245.63 undefined0.26 undefined0.18 undefined
20235.91 undefined0.15 undefined0.06 undefined
20224.28 undefined0.31 undefined0.34 undefined
20213.36 undefined0.2 undefined0.25 undefined
20201.61 undefined-0.19 undefined-0.25 undefined

DocGo business model

The history of DocGo Inc began in 2014 when the idea was born to develop a mobile app for doctor appointment scheduling and health monitoring. The founders recognized a rising demand for faster and more convenient access to medical services. From this vision, DocGo Inc was created. DocGo Inc's business model includes a range of mobile applications that improve access to medical care. The main application is DocGo, which allows users to book doctor appointments and track and manage their health data. This app also offers a feature for monitoring chronic conditions such as diabetes or high blood pressure and automatically sends reports on the status of these conditions to the user's doctor. Another important product from DocGo is the telemedicine system, which allows users to receive early assessments and diagnoses from doctors through video and chat. This helps avoid many cases where patients need to physically visit a doctor, saving time and money. DocGo has also developed a mobile pharmacy app that allows patients to order their medications directly through the app and have them delivered to their homes. This app also has interactive features such as a reminder function that notifies the user when to take their medications. Another important aspect of DocGo is its integration with wearables, which allows users to measure and send their health data to the app in real time. DocGo also utilizes artificial intelligence and machine learning to identify health risks in users and provide recommendations for medications and treatments. In recent years, DocGo has expanded in various areas. The company has formed partnerships with major healthcare organizations and hospitals to create a broader network of care. DocGo has also developed an API that allows other companies to integrate their health data into the DocGo system. Overall, DocGo has made a significant contribution to improving access to medical care, particularly during the COVID-19 pandemic. By providing telemedicine and mobile pharmacy services, as well as managing health data, DocGo has helped democratize and enhance healthcare. DocGo is one of the most popular companies on Eulerpool.com.

DocGo SWOT Analysis

Strengths

DocGo Inc is backed by a highly experienced and competent team of medical professionals, software engineers, and business experts. This diverse expertise enables the company to develop innovative and effective solutions for the healthcare industry.

The company's flagship product, DocGo App, provides a user-friendly interface that allows patients to easily manage their medical records, schedule appointments, and communicate with healthcare providers. This convenience enhances patient satisfaction and engagement.

DocGo Inc has established strong partnerships with leading healthcare institutions and medical professionals. These partnerships help the company to expand its reach, improve product quality, and gain a competitive edge in the market.

Weaknesses

Being a relatively new entrant in the market, DocGo Inc faces challenges in terms of brand recognition and establishing trust among potential users. This could lead to slower adoption rates and difficulty in attracting a large user base initially.

The company's reliance on technology and digital platforms for its services may pose a barrier to adoption for individuals who are less tech-savvy or have limited access to digital devices and internet connectivity.

Opportunities

The increasing adoption of telemedicine and remote healthcare services presents a significant opportunity for DocGo Inc. The company's platform can facilitate virtual consultations, remote monitoring, and electronic prescriptions, addressing the growing demand for convenient and efficient healthcare solutions.

DocGo Inc can explore collaborations with insurance providers to integrate their platform with insurance networks. This would enable seamless claims processing, streamlined healthcare management, and improved cost efficiency for patients and healthcare facilities alike.

Expansion into international markets, where telemedicine and digital health solutions are gaining traction, can provide DocGo Inc with access to a larger customer base and increased revenue streams. Localizing the platform to cater to specific languages and healthcare systems would be necessary for success in these markets.

Threats

The competitive landscape in the digital healthcare industry is intensifying, with both established players and new startups entering the market. DocGo Inc needs to differentiate its offerings and continuously innovate to stay ahead and maintain market share.

Data security and privacy concerns are critical in the healthcare sector. Any breach or unauthorized access to patient data could lead to severe reputational damage and legal consequences. DocGo Inc must invest in robust security measures to protect users' sensitive information.

Regulatory compliance is another potential threat for DocGo Inc. The company must stay updated with evolving healthcare regulations and ensure its platform adheres to data protection, user privacy, and medical compliance standards in all jurisdictions where it operates.

DocGo Revenue by Segment

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

DocGo Revenue by Segment

Segmente2023
Mobile Health Services442.79 M USD
Transportation Services181.5 M USD

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

DocGo Revenue by Segment

Segmente2023
Corporate-

DocGo Revenue by Region

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

DocGo Revenue by Segment

DateUnited KingdomUnited States
202352.4 M USD571.89 M USD
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

DocGo Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

DocGo historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

DocGo shares outstanding

The number of shares was DocGo in 2024 — This indicates how many shares 109.423 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue DocGo earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates DocGo's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of DocGo’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating DocGo's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

DocGo stock splits

In DocGo's history, there have been no stock splits.
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for DocGo.

DocGo latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2025-0.1 -0.11  (-14.35 %)2025 Q2
3/31/2025-0.02 -0.09  (-310.96 %)2025 Q1
12/31/20240.05 0.04  (-19.19 %)2024 Q4
9/30/20240.05 0.05  (1.01 %)2024 Q3
6/30/20240.08 0.07  (-8.5 %)2024 Q2
3/31/20240.08 0.1  (20.34 %)2024 Q1
12/31/20230.1 0.07  (-31.37 %)2023 Q4
9/30/20230.06 0.05  (-20.51 %)2023 Q3
6/30/20230.03 -0.02  (-165.36 %)2023 Q2
3/31/20230.02 -0.03  (-235.75 %)2023 Q1
1
2

Eulerpool ESG Scorecard© for the DocGo stock

Eulerpool World ESG Rating (EESG©)

31/ 100

🌱 Environment

10

👫 Social

67

🏛️ Governance

16

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees4
Share of Asian management11
Percentage of Hispanic/Latino employees19
Hispano/Latino Management share12
Percentage of Black employees31
Black Management Share10
Percentage of white employees40
White Management Share60
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

DocGo shareholders

%
Name
Stocks
Change
Date
5.35651 % BlackRock Institutional Trust Company, N.A.5,861,248-737,4456/30/2025
4.85832 % The Vanguard Group, Inc.5,316,110-153,1186/30/2025
4.71181 % Vashovsky (Stanley)5,155,79911,5514/4/2025
4.51603 % Deerfield Management Company, L.P.4,941,565-109,9356/30/2025
2.92444 % P.A.W. Capital Partners, LP3,200,0001,200,0006/30/2025
2.80641 % Knott Partners Management, LLC3,070,85006/30/2025
2.63043 % S Squared Technology, LLC2,878,286987,3106/30/2025
1.97034 % Geode Capital Management, L.L.C.2,156,001-142,9786/30/2025
1.95979 % Jefferies LLC2,144,456115,0006/30/2025
1.75257 % State Street Global Advisors (US)1,917,710-24,7506/30/2025
1
2
3
4
5
...
10

DocGo Executives and Management Board

Mr. Lee Bienstock

(40)
DocGo Chief Executive Officer, Director (since 2022)
Compensation 11.35 M

Mr. Norman Rosenberg

(54)
DocGo Chief Financial Officer, Treasurer
Compensation 4.17 M

Mr. Stephen Sugrue

(52)
DocGo Chief Compliance Officer
Compensation 2.44 M

Mr. Ely Tendler

(56)
DocGo General Counsel, Company Secretary, Director (since 2021)
Compensation 1.6 M

Mr. Michael Burdiek

(64)
DocGo Independent Director
Compensation 180,000
1
2

Most common questions regarding DocGo

What values and corporate philosophy does DocGo represent?

DocGo Inc represents a strong commitment to providing quality healthcare services through innovative technologies and a patient-centric approach. The company values include integrity, transparency, and a passion for improving healthcare outcomes. DocGo Inc strives to revolutionize the medical transportation industry by offering efficient and reliable services that prioritize patient safety and comfort. With a customer-focused philosophy, DocGo Inc aims to deliver exceptional value to both its clients and shareholders.

In which countries and regions is DocGo primarily present?

DocGo Inc is primarily present in multiple countries and regions around the world. Some of the key locations where DocGo Inc operates include the United States, Canada, Europe, and Asia. With a global presence, DocGo Inc has established a strong foothold in these regions, allowing them to provide their stock services and solutions to a wide range of international clients. Whether you are based in North America, Europe, or Asia, DocGo Inc is committed to delivering exceptional stock services and maintaining a strong presence in multiple countries and regions.

What significant milestones has the company DocGo achieved?

Some significant milestones achieved by DocGo Inc include the successful development and launch of their advanced medical technology solutions, which have revolutionized the healthcare industry. The company has also garnered recognition for their groundbreaking research and innovation in areas such as telemedicine, patient monitoring, and data analysis. DocGo Inc's commitment to excellence is demonstrated through their partnerships with leading healthcare organizations and the continuous improvement of their products and services. With a focus on improving patient outcomes and delivering high-quality healthcare solutions, DocGo Inc continues to make significant strides in the industry.

What is the history and background of the company DocGo?

DocGo Inc is a leading company in the healthcare industry. Founded in [year], it has established itself as a trusted provider of innovative healthcare solutions. With a strong focus on improving patient outcomes, DocGo Inc offers a wide range of services including telehealth, remote patient monitoring, and medical device development. The company has a team of highly skilled professionals dedicated to delivering state-of-the-art technology and personalized care. DocGo Inc has consistently demonstrated its commitment to revolutionizing the healthcare industry, and its name has become synonymous with excellence and cutting-edge advancements in the field.

Who are the main competitors of DocGo in the market?

The main competitors of DocGo Inc in the market include companies like E-Trip, MedTech Solutions, and HealthNet Innovations.

In which industries is DocGo primarily active?

DocGo Inc is primarily active in the healthcare industry.

What is the business model of DocGo?

The business model of DocGo Inc revolves around providing on-demand medical transportation services. As a mobile medical transportation platform, DocGo Inc utilizes advanced technology to connect healthcare providers, patients, and medical transportation providers. Through their efficient platform, DocGo Inc ensures timely and reliable transportation for patients with non-emergency medical needs, enhancing access to medical care. By offering this convenient and reliable solution, DocGo Inc aims to improve the overall healthcare experience and help healthcare providers streamline their operations.

What is the P/E ratio of DocGo 2025?

The P/E ratio cannot be calculated for DocGo at the moment.

What is the P/S ratio of DocGo 2025?

The P/S cannot be calculated for DocGo currently.

What is the Quality Investing of DocGo?

The Quality Investing for DocGo is 3/10.

What is the revenue of DocGo 2025?

The expected DocGo revenue is 324.34 M USD.

How high is the profit of DocGo 2025?

The expected DocGo profit is -49.56 M USD.

What is the business model of DocGo

DocGo Inc is an innovative company specialized in providing medical services through mobile health and care teams. Its business model includes various divisions and products that enable the company to effectively and efficiently meet the needs of customers and patients. One of the main divisions of DocGo Inc is the provision of medical services for patients in emergencies. This includes providing mobile intensive care units that can offer immediate medical assistance to patients in critical conditions. The teams of DocGo Inc are specially trained and equipped to act quickly and safely in any situation. This service is particularly important for patient transportation between facilities or to bridge waiting times for appointments. Another important division of DocGo Inc is telemedicine. This involves the medical care of patients through digital communication means such as phone calls, video calls, and text messages. This type of medical care is especially suitable for patients who have difficulties accessing a clinic or hospital. Additionally, it can help reduce long waiting times at the doctor's office or in the emergency room. DocGo Inc's telemedicine is easily accessible and provides a fast and reliable connection to an experienced doctor. Another product offered by DocGo Inc is mobile diagnostics. This includes conducting medical tests and examinations through mobile teams that come directly to the patient's location. This product is particularly suitable for people who have difficulties accessing a clinic or hospital but still require medical examinations. The mobile teams of DocGo Inc are specially trained and equipped with the latest medical devices and technologies. Furthermore, DocGo Inc also offers training for medical personnel and laypeople, especially those working or living in emergency situations. These trainings include courses in first aid, life-saving techniques, and medical care. These trainings are invaluable for companies and organizations that want to prepare their employees for emergencies, as well as for individuals who want to be ready to act in emergency situations. Overall, the business model of DocGo Inc is focused on providing medical services to patients quickly, reliably, and with minimal restrictions. The mobile teams of DocGo Inc are highly qualified and specially trained to act quickly and safely in any situation. The telemedicine and mobile diagnostics services are particularly suitable for patients who have difficulties accessing clinics or hospitals. Finally, DocGo Inc's trainings improve the skills of medical personnel and laypeople, ultimately saving lives in emergencies.

What is the DocGo dividend?

DocGo pays a dividend of 0 USD distributed over payouts per year.

How often does DocGo pay dividends?

The dividend cannot currently be calculated for DocGo or the company does not pay out a dividend.

What is the DocGo ISIN?

The ISIN of DocGo is US2560861096.

What is the DocGo ticker?

The ticker of DocGo is DCGO.

How much dividend does DocGo pay?

Over the past 12 months, DocGo paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, DocGo is expected to pay a dividend of 0 USD.

What is the dividend yield of DocGo?

The current dividend yield of DocGo is .

When does DocGo pay dividends?

DocGo pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of DocGo?

DocGo paid dividends every year for the past 0 years.

What is the dividend of DocGo?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is DocGo located?

DocGo is assigned to the 'Health' sector.

Wann musste ich die Aktien von DocGo kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of DocGo from 9/28/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/28/2025.

When did DocGo pay the last dividend?

The last dividend was paid out on 9/28/2025.

What was the dividend of DocGo in the year 2024?

In the year 2024, DocGo distributed 0 USD as dividends.

In which currency does DocGo pay out the dividend?

The dividends of DocGo are distributed in USD.

All fundamentals about DocGo

Our stock analysis for DocGo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DocGo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.